This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
British Menopause Society Council. Modernizing the NHS: observations and recommendations from the British Menopause Society. Menopause Int 2011; 17(2): 41–3. doi: 10.1258/mi.2011.011015.British Menopause Society CouncilModernizing the NHS: observations and recommendations from the British Menopause Society201117241310.1258/mi.2011.01101521693497Open DOISearch in Google Scholar
Daan NMP, Fauser BCJM. Menopause prediction and potential implications. Maturitas 2015; 82(3): 257–265. doi: 10.1016/j.maturitas.2015.07.019.DaanNMPFauserBCJMMenopause prediction and potential implications201582325726510.1016/j.maturitas.2015.07.01926278873Open DOISearch in Google Scholar
Duckitt K. Managing perimenopausal menorrhagia. Maturitas 2010; 66(3): 251–256. doi: 10.1016/j.maturitas.2010.03.013.DuckittKManaging perimenopausal menorrhagia201066325125610.1016/j.maturitas.2010.03.01320399041Open DOISearch in Google Scholar
Birdwood GF. Understanding Osteoporosis and its Treatment. 1996. Pearl River, NY: The Parthenon Publishing Group, Inc.BirdwoodGF1996Pearl River, NYThe Parthenon Publishing Group, Inc.Search in Google Scholar
Burger HG. Androgen production in women. Fertil Steril 2002; 77 Suppl 4: S3–S5. doi: 10.1016/s0015-0282(02)02985-0.BurgerHGAndrogen production in women200277Suppl 4S3S510.1016/s0015-0282(02)02985-012007895Open DOISearch in Google Scholar
Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep 2004; 119 (3): 263–270. doi: 10.1016/j.phr.2004.04.005.AndersonGHorvathJThe growing burden of chronic disease in America2004119326327010.1016/j.phr.2004.04.005149763815158105Open DOISearch in Google Scholar
Chapin J. Von Willebrand disease in the elderly: clinical perspectives. Clin Interv Aging 2018; 13: 1531–1541. doi: 10.2147/CIA.S136931.ChapinJVon Willebrand disease in the elderly: clinical perspectives2018131531154110.2147/CIA.S136931612446230214173Open DOISearch in Google Scholar
Biguzzi E, Siboni SM, le Cessie S, et al. Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease. J Thromb Haemost 2021; 19(1): 96–106. doi: 10.1111/jth.15116.BiguzziESiboniSMle CessieSIncreasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease20211919610610.1111/jth.1511632998182Open DOISearch in Google Scholar
Rejtö J, Königsbrügge O, Grilz E, et al. Influence of blood group, von Willebrand factor levels and age on factor VIII levels in non-severe haemophilia A. J Thromb Haemost 2020; 18(5): 1081–1086. doi: 10.1111/jth.14770RejtöJKönigsbrüggeOGrilzEInfluence of blood group, von Willebrand factor levels and age on factor VIII levels in non-severe haemophilia A20201851081108610.1111/jth.14770731858632073230Open DOISearch in Google Scholar
Miesbach W, Alesci S, Krekeler S, Seifried E. Age-dependent increase of FVIII:C in non-severe haemophilia A. Haemophilia 2009; 15(5): 1022–6. doi: 10.1111/j.1365-2516.2009.02051.x.MiesbachWAlesciSKrekelerSSeifriedEAge-dependent increase of FVIII:C in non-severe haemophilia A20091551022610.1111/j.1365-2516.2009.02051.x19493020Open DOISearch in Google Scholar
Miesbach W, Alesci S, Krekeler S, Seifried E. Comorbidies and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009; 15(4): 894–9. doi: 10.1111/j.1365-2516.2009.02030.x.MiesbachWAlesciSKrekelerSSeifriedEComorbidies and bleeding pattern in elderly haemophilia A patients2009154894910.1111/j.1365-2516.2009.02030.x19473414Open DOISearch in Google Scholar
Seaman CD, Ragni MV. The association of aging with von Willebrand factor levels and bleeding in type 1 von Willebrand disease. Clin Appl Thromb Hemost 2018; 24(3): 434–438. doi: 10.1177/1076029617724232.SeamanCDRagniMVThe association of aging with von Willebrand factor levels and bleeding in type 1 von Willebrand disease201824343443810.1177/1076029617724232671466428874064Open DOISearch in Google Scholar
Seaman CD, Ragni MV. The effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease. Thromb Haemost 2020; 120(08): 1159–1165. doi: 10.1055/s-0040-1713636.SeamanCDRagniMVThe effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease2020120081159116510.1055/s-0040-171363632629500Open DOISearch in Google Scholar
Bolton-Maggs PHB, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135(5): 603–33. doi: 10.1111/j.1365-2141.2006.06343.x.Bolton-MaggsPHBChalmersEACollinsPWA review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO200613556033310.1111/j.1365-2141.2006.06343.x17107346Open DOISearch in Google Scholar
George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75(7): 1383–1395. doi: 10.1182/blood.V75.7.1383.1383.GeorgeJNCaenJPNurdenATGlanzmann's thrombasthenia: the spectrum of clinical disease19907571383139510.1182/blood.V75.7.1383.1383Open DOISearch in Google Scholar
Casini A, Neerman-Arbez, de Moerloose P. Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management. Blood Rev 2021; 48: 100793. doi: 10.1016/j.blre.2020.100793.CasiniANeerman-Arbezde MoerloosePHeterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management20214810079310.1016/j.blre.2020.10079333419567Open DOISearch in Google Scholar
Siboni SM, Mannucci PM, Gringeri A. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7(5): 780–6. doi: 10.1111/j.1538-7836.2009.03318.x.SiboniSMMannucciPMGringeriAHealth status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy200975780610.1111/j.1538-7836.2009.03318.x19220727Open DOISearch in Google Scholar
Srámek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003; 362 (9381): 351–354. doi: 10.1016/s0140-6736(03)14021-4.SrámekAKriekMRosendaalFRDecreased mortality of ischaemic heart disease among carriers of haemophilia2003362938135135410.1016/s0140-6736(03)14021-412907007Open DOISearch in Google Scholar
Schutgens REG, Voskuil M, Mauser-Bunschoten EP. Management of cardiovascular disease in aging persons with haemophilia. Hamostaseologie 2017; 37(3): 196–201. doi: 10.5482/HAMO-16-09-0037.SchutgensREGVoskuilMMauser-BunschotenEPManagement of cardiovascular disease in aging persons with haemophilia201737319620110.5482/HAMO-16-09-003727966004Open DOISearch in Google Scholar
Dilshad H, Yousuf RI, Shoaib MH, Jamil S, Khatoon H. Cardiovascular disease risk associated with the long-term use of depot medroxyprogesterone acetate. Am J Med Sci 2016; 352(2): 487–492. doi: 10.1016/j.amjms.2016.08.007.DilshadHYousufRIShoaibMHJamilSKhatoonHCardiovascular disease risk associated with the long-term use of depot medroxyprogesterone acetate2016352248749210.1016/j.amjms.2016.08.00727865296Open DOISearch in Google Scholar